» Articles » PMID: 25297113

Reducing the Risk of Infection in End-stage Kidney Failure Patients Treated by Dialysis

Overview
Date 2014 Oct 10
PMID 25297113
Citations 16
Authors
Affiliations
Soon will be listed here.
Citing Articles

Colonisation with multidrug-resistant organisms among dialysis patients at Universitas Academic Hospital.

Shamhuyashe G, van Zyl N, van Rooyen C, Bisiwe F, Musoke J S Afr J Infect Dis. 2024; 39(1):607.

PMID: 39114261 PMC: 11304359. DOI: 10.4102/sajid.v39i1.607.


Monocytes as Targets for Immunomodulation by Regional Citrate Anticoagulation.

Di Marco G, Chasan A, Boeckel G, Beul K, Pavenstadt H, Roth J Int J Mol Sci. 2024; 25(5).

PMID: 38474146 PMC: 10932113. DOI: 10.3390/ijms25052900.


Comparison of Acute Health Care Utilization Between Patients Receiving In-Center Hemodialysis and the General Population: A Population-Based Matched Cohort Study From Ontario, Canada.

Naylor K, Vinegar M, Blake P, Bota S, Luo B, Garg A Can J Kidney Health Dis. 2024; 11:20543581241231426.

PMID: 38449711 PMC: 10916490. DOI: 10.1177/20543581241231426.


Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol.

Zhao X, Zuo L BMJ Open. 2023; 13(9):e066394.

PMID: 37734899 PMC: 10514616. DOI: 10.1136/bmjopen-2022-066394.


Outbreak of drug resistance phylogenetic F group associated urinary tract infection.

Mohsin A, Alsakini A, Ali M Iran J Microbiol. 2023; 14(3):341-350.

PMID: 37124864 PMC: 10132334. DOI: 10.18502/ijm.v14i3.9771.


References
1.
Pahl M, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri N . Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2009; 25(1):205-12. PMC: 2796898. DOI: 10.1093/ndt/gfp397. View

2.
Carson R, Juszczak M, Davenport A, Burns A . Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease?. Clin J Am Soc Nephrol. 2009; 4(10):1611-9. PMC: 2758251. DOI: 10.2215/CJN.00510109. View

3.
van Manen J, Korevaar J, Dekker F, Boeschoten E, Bossuyt P, Krediet R . Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use?. J Am Soc Nephrol. 2003; 14(2):478-85. DOI: 10.1097/01.asn.0000043902.30577.c9. View

4.
van Diepen A, Hoekstra T, Rotmans J, de Boer M, le Cessie S, Suttorp M . The association between dialysis modality and the risk for dialysis technique and non-dialysis technique-related infections. Nephrol Dial Transplant. 2014; 29(12):2244-50. DOI: 10.1093/ndt/gfu285. View

5.
Zoccali C, Puntorieri E, Mallamaci F . Lung congestion as a hidden threat in end-stage kidney disease: a call to action. Nephrol Dial Transplant. 2013; 28(11):2657-60. DOI: 10.1093/ndt/gft425. View